Pulished Date October, 2018
ID: 7861
Share on
Share on

North America Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung Cancer, Other Cancers), By Region - North America Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 7861
Pages: 145

North America Non-Invasive Cancer Diagnostics market size was approximately USD 41.8 billion in 2018 and showing a huge increase with a CAGR of 6.5 % and is anticipated to reach USD 57.27 billion by 2023.

Non-Invasive Cancer is a type of multicentre cancer, in which the tumours formed will spread out the entire place where they are formed. DCIS is a Non-Invasive Cancer generally found in milk ducts and this is a type of breast cancer.   

The hike in this market is driven by several factors some of them include an increase in the number of people who are diagnosed with cancer every year, smoking tobacco, exposing the body to different types of radiations, heredity, chemicals. Introducing new ways of treating cancers also increasing the market share. The high cost of treatment may drag back the market value in some of the developing countries.

The market is segmented by technology and by therapeutics. By technology, the market is categorized into molecular diagnostics, clinical chemistry, clinical instruments, and immunochemistry. With the advancement in technology, the market of molecular diagnostics is increasing at an exponential rate. By therapeutics, the market is further divided into solid tumours, breast cancer, blood cancer, lung cancer, and other cancers. According to recent studies every year, more than 15 million new cancer cases are diagnosed and most of them are found to be breast cancers and lung cancers. Breast cancer accounted for the major market share in the recent years. Many non-profit organizations came into the picture to help people and increased awareness about symptoms and treatment process of the breast cancer which is helping the market to increase its size. Lung cancer is one of the major types of cancer diagnosed in huge number and the number is increasing every year.

By geography, the market is segmented into US and Canada. North America holds the largest share of the global market of non-invasive cancer due to the higher penetration of technology to the majority of the populace and good healthcare scenario in the region.

Companies providing the best treatment for cancer in the market include Gen Probe Inc., Abbott Laboratories, Quest Diagnostics Inc., Cancer Genetics Inc., Hologic Inc., Myriad Genetics Inc., Bioview Inc., Volcano Corp., Laboratory Corporation of America Holdings, Precision Therapeutics. Digene Corporation.


                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 Molecular Diagnostics        

                                5.1.3 Clinical Chemistry 

                                5.1.4 Clinical Instruments             

                                5.1.5 Immunochemistry               

                                5.1.6 Y-o-Y Growth Analysis, By Technology        

                                5.1.7  Market Attractiveness Analysis, By Technology     

                                5.1.8  Market Share Analysis, By Technology       

                5.2 Therapeutics                              

                                5.2.1 Introduction           

                                5.2.2 Solid Tumours        

                                5.2.3 Blood Cancer          

                                5.2.4 Lung Cancer            

                                5.2.5 Breast Cancer        

                                5.2.6 Y-o-Y Growth Analysis, By Therapeutics     

                                5.2.7 Market Attractiveness Analysis, By Therapeutics   

                                5.2.8 Market Share Analysis, By Therapeutics     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Technology

                                       By Therapeutics

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Thechnology

                                       By Therapeutics

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Technology

                                       By Therapeutics

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Gen Probe Inc                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories                               

                8.3 Quest Diagnostics                    

                8.4 Cancer Genetics                       

                8.5 Hologic Inc                  

                8.6 Myraid Genetics                       

                8.7 Bioview Inc                 

                8.8 Volcano Corp                             

                8.9 Laboratory Corporation Of America Holdings                               

                8.10 Precision Therapeutics                        

                8.11 Digene Corporation                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Technology, by Therapeutics along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. North America Non-Invasive Cancer Diagnostics Market By Technology, From 2018-2023 ( USD Billion )
  2. North America Molecular Diagnostics Market By Region, From 2018-2023 ( USD Billion )
  3. North America Clinical Chemistry Market By Region, From 2018-2023 ( USD Billion )
  4. North America Clinical Instruments Market By Region, From 2018-2023 ( USD Billion )
  5. North America Immunochemistry Market By Region, From 2018-2023 ( USD Billion )
  6. North America Non-Invasive Cancer Diagnostics Market By Therapeutics, From 2018-2023 ( USD Billion )
  7. North America Solid Tumours Market By Region, From 2018-2023 ( USD Billion )
  8. North America Breast Cancer Market By Region, From 2018-2023 ( USD Billion )
  9. North America Blood Cancer Market By Region, From 2018-2023 ( USD Billion )
  10. North America Lung Cancer Market By Region, From 2018-2023 ( USD Billion )
  11. North America Other Cancers Market By Region, From 2018-2023 ( USD Billion )
  12. United States Non-Invasive Cancer Diagnostics Market By Technology, From 2018-2023 ( USD Billion )
  13. United States Non-Invasive Cancer Diagnostics Market By Therapeutics, From 2018-2023 ( USD Billion )
  14. Canada Non-Invasive Cancer Diagnostics Market By Technology, From 2018-2023 ( USD Billion )
  15. Canada Non-Invasive Cancer Diagnostics Market By Therapeutics, From 2018-2023 ( USD Billion )


$ 1234 3335